Medivolve Inc MEDVF

Healthcare Copper

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.

OTCPK:MEDVF - Post by User

Medivolve Inc > Here is the math, and anyone can suggest corrections.

<< Previous

Bullboard Posts

Next >>

Post by Sarb99on Dec 22, 2020 10:02pm

311 Views

Post# 32166891

Here is the math, and anyone can suggest corrections.

By this weekend, QuestCap should have about 45 testing sites up and running. So, we will use the 7-day rolling average of 82 tests per day per site and an average test price of $85 per test;

These 45 testing sites perform 45x82=3690 tests each day, and revenue is 3690x$85=$313,650 each day. Now, we calculate $313,650x30=$9,409,500 per month. These calculations are for USD now convert this amount to Canadian Dollars $9,409,500x1.29=$12,138,255. and yearly revenue should be $145,659,060.

Now we can calculate the profit margin of $145,659,060 and use lower than the company projected EBTIDA 50% = $72,859,530 (Company projected EBITDA is 55%) https://www.omnicalculator.com/finance/margin

So without any P/E rato, the QSC share price should be somewhere 0.48 cents. Most of the companies in the medical field use a PE Ratio between 5 to 40. You can calculate the P/E Ratio as you like. Whatever P/E Ratio you use or even without any P/E Ratio, QuestCap share price should be much higher. https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html

Now fast forward to the mid-end of January, when Medi-volve should have 100+ tasting centres up and running. At that point, revenue/earning/stock price jumps to more than double. 100x82=8200 test per day generating $697,00 per day and USD 20,910,000 that comes to $26,973,900 Canadian per Month. That is $323,686,800 per year, and the projected EBTIDA calculation with 50% comes to $161,843,400. Little over a $1 per share, and even with a P/E Ration of 5, Medi-Volve should be trading over $5.

According to QuestCap management, we should see over 700 testing sites by the end of March. After January, we will see where is this company is heading and calculate then. These 700 testing sites can bring a large sum of revenue and, in return, higher stock price.

Here is another stream that adds more revenue.

RESAAS selling testing kits to 500,000 realtors and online in the USA, Australia and Spain. Sanaty IPS with two locations offering medical service and Covid-19 testing in Columbia S.A.

After Pandemic, Medi-Vole can move to any of these options;